Back
ClearPoint Neuro, Inc. 10K Form
Sell
15
CLPT
ClearPoint Neuro, Inc.
Last Price:
$9.36
Seasonality Move:
-7.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLPT News And Ratings
See the #1 stock for the next 7 days that we like better than CLPT
CLPT Financial Statistics
Sales & Book Value
| Annual Sales: | $37M |
|---|---|
| Cash Flow: | $-12.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.95 |
| Price / Book: | 9.92 |
Profitability
| EPS (TTM): | -0.90220 |
|---|---|
| Net Income (TTM): | $-25.5M |
| Gross Margin: | $22.6M |
| Return on Equity: | -117.14% |
| Return on Assets: | -43.53% |
ClearPoint Neuro, Inc. Earnings Forecast
Key ClearPoint Neuro, Inc. Financial Ratios
-
The Gross Profit Margin over the past 19 years for CLPT is 61.19%.
-
The Selling, General & Administrative Expenses for CLPT have been equal to 89.15% of Gross Profit Margin.
-
The Research & Development expenses have been 37.59% of Revenue.
-
The Net Earning history of CLPT is -69.08% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 9 years.
ClearPoint Neuro, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | CLPT |
| CUSIP: | 18507C |
| Website: | clearpointneuro.com |
Debt
| Debt-to-Equity Ratio: | 2.08 |
|---|---|
| Current Ratio: | 5.89 |
| Quick Ratio: | 5.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLPT Technical Analysis vs Fundamental Analysis
Sell
15
ClearPoint Neuro, Inc. (CLPT)
is a Sell
Is ClearPoint Neuro, Inc. a Buy or a Sell?
-
ClearPoint Neuro, Inc. stock is rated a SellThe current ClearPoint Neuro, Inc. [CLPT] share price is $9.37. The Score for CLPT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.